Industry Educational Session - Follicular Lymphoma: Advancing care beyond second line - Sponsored by Abbvie
Tracks
-
| Monday, April 20, 2026 |
| 5:05 PM - 5:35 PM |
| Hall 3A, Upper Level |
Details
This AbbVie promotional symposium, “Follicular Lymphoma: Advancing care beyond second line,” will explore recent progress in the management of 3L+ follicular lymphoma, with a focus on bispecific antibodies as a treatment option and what this means for clinical practice. The programme will discuss the evolving treatment landscape, review key clinical data, and discuss considerations on identifying appropriate patients for therapies based on disease features, prior treatments and patient specific factors. Attendees will hear expert perspectives and have the opportunity to participate in a live Q&A session.
This promotional symposium is organised and funded by AbbVie UK and is intended for UK healthcare professionals only.
AbbVie products will be discussed. Prescribing information and adverse event reporting information will be available at the symposium.
UK-EPCOR-260081, Feb 2026
Speaker
Prof. Kim Linton
Professor
The Christie NHS Foundation Trust, Manchester Cancer Research Centre & Division of Cancer Sciences, Univ of Manchester
Speaker One
Kim Linton is a Professor of Medical Oncology at the University of Manchester and an Honorary Consultant at The Christie NHS Foundation Trust.
Professor Jessica Okosun
Consultant Haematologist
Barts Cancer Institute, QMUL
Speaker Two
Jessica Okosun, MA, MB BChir, MRCP, FRCPath, PhD, is a clinical senior lecturer at the Barts Cancer Institute, Queen Mary University of London, London, UK, and consultant haematologist at St Bartholomew’s Hospital, London, UK.
